74 Publications (Page 2 of 3)
2014
Comparison of an assumption-free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing.
Laínez, José MOrcun, SezaPekny, Joseph FReklaitis, Gintaras VSuvannasankha, AttayaFausel, ChristopherAnaissie, Elias J and Blau, Gary E
Pharmacotherapy, vol. 34, (no. 4), pp. 330-5, 2014/Apr. | Journal Article
 
Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15.
Timani, Khalid AmineLiu, YingSuvannasankha, Attaya and He, Johnny J
The international journal of biochemistry & cell biology, vol. 54, pp. 10-19, September 2014. | Journal Article
 
Role of bone-anabolic agents in the treatment of breast cancer bone metastases.
Suvannasankha, Attaya and Chirgwin, John M
Breast cancer research : BCR, vol. 16, (no. 6), pp. 484, 2014. | Journal Article
 
Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
Siclari, Valerie AMohammad, Khalid STompkins, Douglas RDavis, HollyMcKenna, C RyanPeng, XianghongWessner, Lisa LNiewolna, MariaGuise, Theresa ASuvannasankha, Attaya and Chirgwin, John M
Breast cancer research : BCR, vol. 16, (no. 6), pp. 458, December 2, 2014. | Journal Article
2013
Neonatal Mouse Bone Supports Growth Of Primary Myeloma Cells Ex Vivo and Assessment Of Responses To Antimyeloma Drugs
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaTompkins, Douglas RTompkins, Douglas RTompkins, Douglas RPetyaykina, KaterynaPetyaykina, KaterynaPetyaykina, KaterynaCrean, Colin DCrean, Colin DCrean, Colin DCondon, Keith WCondon, Keith WCondon, Keith WDavid Roodman, G. DavidDavid Roodman, G. DavidDavid Roodman, G. DavidChirgwin, John MChirgwin, John M and Chirgwin, John M
Blood, vol. 122, (no. 21), pp. 1893, 2013-11-15. | Journal Article
 
Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression
Xu, LinlinXu, LinlinXu, LinlinXu, LinlinXu, LinlinMachal, ChristopheMachal, ChristopheMachal, ChristopheMachal, ChristopheMachal, ChristopheWu, HaoWu, HaoWu, HaoWu, HaoWu, HaoPoteat, BradleyPoteat, BradleyPoteat, BradleyPoteat, BradleyPoteat, BradleyCrean, Colin DCrean, Colin DCrean, Colin DCrean, Colin DCrean, Colin DCardoso, Angelo ACardoso, Angelo ACardoso, Angelo ACardoso, Angelo ACardoso, Angelo AChirgwin, John MChirgwin, John MChirgwin, John MChirgwin, John MChirgwin, John MHanenberg, HelmutHanenberg, HelmutHanenberg, HelmutHanenberg, HelmutHanenberg, HelmutMohammad, Khalid SMohammad, Khalid SMohammad, Khalid SMohammad, Khalid SMohammad, Khalid SSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSrour, Edward FSrour, Edward FSrour, Edward FSrour, Edward F and Srour, Edward F
Blood, vol. 122, (no. 21), pp. 3102, 2013-11-15. | Journal Article
 
Temozolomide-mediated DNA methylation in human myeloid precursor cells: differential involvement of intrinsic and extrinsic apoptotic pathways.
Wang, HaiyanWang, HaiyanCai, ShanbaoCai, ShanbaoErnstberger, AaronErnstberger, AaronBailey, Barbara JBailey, Barbara JWang, Michael ZWang, Michael ZCai, WenjingCai, WenjingGoebel, W ScottGoebel, W SCzader, Magdalena BCzader, Magdalena BCrean, ColinCrean, ColinSuvannasankha, AttayaSuvannasankha, AttayaShokolenkoc, InnaShokolenkoc, InnaWilson, Glenn LWilson, Glenn LBaluyut, Arthur RBaluyut, Arthur RMayo, Lindsey DMayo, Lindsey DPollok, Karen E and Pollok, Karen E
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 19, (no. 10), pp. 2699-709, 2013/May/15. | Journal Article
 
Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.
Blau, Gary EOrcun, SezaLaínez, José MReklaitis, Gintaras VSuvannasankha, AttayaFausel, Chris and Anaissie, Elias J
Pharmacotherapy, vol. 33, (no. 7), pp. 727-35, 2013/Jul. | Journal Article
2012
Abstract 5300: Endothelial colony forming cells (ECFCs) in multiple myeloma
Sharma, RohanSuvannasankha, AttayaCrean, Colin and Yoder, Mervin
Cancer Research, vol. 72, (no. 8 Supplement), pp. 5300, 2012-04-15. | Journal Article
 
A Noncanonical Flt3ITD/NF- Kappa B Signaling Pathway Represses DAPK1 in Acute Myeloid Leukemia
Shanmugam, RajasubramaniamShanmugam, RajasubramaniamGade, PadmajaGade, PadmajaWilson-Weekes, AnniqueWilson-Weekes, AnniqueSayar, HamidSayar, HamidSuvannasankha, AttayaSuvannasankha, AttayaGoswami, ChirayuGoswami, ChirayuLi, LangLi, LangGupta, SushilGupta, SushilCardoso, AngeloCardoso, AngeloAl Baghdadi, TareqAl Baghdadi, TareqSargent, KatieSargent, KatieCripe, LarryCripe, LarryKalvakolanu, DhananjayaKalvakolanu, DhananjayaBoswell, HScott and Boswell, HScott
Clinical Cancer Research, vol. 18, (no. 2), pp. 369, 20120115. | Journal Article
 
A noncanonical Flt3ITD/NF-κB signaling pathway represses DAPK1 in acute myeloid leukemia.
Shanmugam, RajasubramaniamGade, PadmajaWilson-Weekes, AnniqueSayar, HamidSuvannasankha, AttayaGoswami, ChirayuLi, LangGupta, SushilCardoso, Angelo AAl Baghdadi, TareqSargent, Katie JCripe, Larry DKalvakolanu, Dhananjaya V and Boswell, H S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 2), pp. 360-9, 2012/Jan/15. | Journal Article
 
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
Benson, Don MHofmeister, Craig CPadmanabhan, SwaminathanSuvannasankha, AttayaJagannath, SundarAbonour, RafatBakan, CourtneyAndre, PascaleEfebera, Yvonne ATiollier, JérômeCaligiuri, Michael A and Farag, Sherif S
Blood, vol. 120, (no. 22), pp. 4324-33, 2012/Nov/22. | Journal Article
 
A Phase I/II Trial Combining High-Dose Lenalidomide with Melphalan and Autologous Transplant for Multiple Myeloma: A Report of the Phase I Dose-Finding Study
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifFarag, SherifSilbermann, RebeccaSilbermann, RebeccaSilbermann, RebeccaObryant, RobinObryant, RobinObryant, RobinWood, Lisa lWood, Lisa lWood, Lisa lHuljak, AbigailHuljak, AbigailHuljak, AbigailSecrest, AngieSecrest, AngieSecrest, AngieCrean, Colin DCrean, Colin DCrean, Colin DAbonour, RafatAbonour, Rafat and Abonour, Rafat
Blood, vol. 120, (no. 21), pp. 3146, 2012-11-16. | Journal Article
 
Early Evidence of Anabolic Bone Activity of BHQ880, a Fully Human Anti-DKK1 Neutralizing Antibody: Results of a Phase 2 Study in Previously Untreated Patients with Smoldering Multiple Myeloma At Risk for Progression
Munshi, Nikhil CMunshi, Nikhil CAbonour, RafatAbonour, RafatBeck, Joseph TBeck, Joseph TBensinger, WilliamBensinger, WilliamFacon, ThierryFacon, ThierryStockerl-Goldstein, KeithStockerl-Goldstein, KeithBaz, RachidBaz, RachidSiegel, David SSiegel, David SNeben, KaiNeben, KaiLonial, SagarLonial, SagarSuvannasankha, AttayaSuvannasankha, AttayaBilic, SanelaBilic, SanelaChica, SandraChica, SandraMukhopadhyay, SubhenduMukhopadhyay, SubhenduIsaacs, RandiIsaacs, RandiJagannath, Sundar and Jagannath, Sundar
Blood, vol. 120, (no. 21), pp. 331, 2012-11-16. | Journal Article
 
Individualizing the starting dose for MPT therapy in elderly myeloma patients
Blau, Gary EOrcun, SezaLainez, Jose MiguelReklaitis, Gintaras VSuvannasankha, AttayaFausel, Christopher AKiel, Patrick and Anaissie, Elias J
Journal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. e18555, 2012-05-20. | Journal Article
2011
A Potential Biomarker Panel of Multiple Myeloma Identified Using Label-Free Mass Spectrometry-Based Quantitative Proteomics
Suvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaCrean, Colin DCrean, Colin DCrean, Colin DSahm, Heather MSahm, Heather MSahm, Heather MAbonour, RafatAbonour, RafatAbonour, RafatFarag, SherifFarag, SherifFarag, SherifWang, MuWang, Mu and Wang, Mu
Blood, vol. 118, (no. 21), pp. 2890, 2011-11-18. | Journal Article
 
Assessment of Free Light Chains in the Ascites and Pleural Effusion in Patients with Multiple Myeloma: A Report of 2 Cases
Rashdan, SawsanRashdan, SawsanFarag, SherifFarag, SherifAbonour, RafatAbonour, RafatSuvannasankha, Attaya and Suvannasankha, Attaya
Blood, vol. 118, (no. 21), pp. 5078, 2011-11-18. | Journal Article
 
Bortezomib (Velcade) treatment of AL amyloidosis: Indiana University experience.
Abonour, RafatKramer, GSuvannasankha, Attaya and Benson, M D
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, vol. 18 Suppl 1, pp. 151, 2011/Jun. | Journal Article
 
The novel histone deacetylase inhibitor, AR-42, inhibits gp130/Stat3 pathway and induces apoptosis and cell cycle arrest in multiple myeloma cells
Zhang, ShuhongZhang, ShuhongSuvannasankha, AttayaSuvannasankha, AttayaCrean, Colin DCrean, Colin DWhite, Valerie LWhite, Valerie LChen, Ching ShihChen, Ching‐ShihFarag, Sherif S and Farag, Sherif S
International Journal of Cancer, vol. 129, (no. 1), pp. 204-213, 2011. | Journal Article
2010
Assessment of the Performance of Serum Heavy Chains Immunoassay to Monitor Response to Treatment and Its Correlation with Other Tumor Measurements In Serial Samples From Patients with Newly Diagnosed MM
Suvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifHarding, StephenHarding, StephenDurie, Brian GMDurie, Brian GMAbonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 2986, 2010-11-19. | Journal Article
 
Clinical Activity of a Novel Multiple Tyrosine Kinase and Aurora Kinase Inhibitor, ENMD-2076, Against Multiple Myeloma: Interim Phase I Trial Results
Farag, SherifFarag, SherifFarag, SherifZhang, ShuhongZhang, ShuhongZhang, ShuhongSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaLiang, JingLiang, JingLiang, JingO'Bryant, RobynO'Bryant, RobynO'Bryant, RobynLisa, WoodLisa, WoodLisa, WoodGupta, SushilGupta, SushilGupta, SushilBray, MarkBray, MarkBray, MarkSidor, Carolyn FowlerSidor, Carolyn FowlerSidor, Carolyn FowlerAbonour, RafatAbonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 1957, 2010-11-19. | Journal Article
 
IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody for Multiple Myeloma: Interm Phase 1 Trial Results and Correlative Biologic and Safety Data
Benson, Don MBenson, Don MBakan, Courtney EBakan, Courtney EPadmanaban, SwaminathanPadmanaban, SwaminathanAbonour, RafatAbonour, RafatSuvannasankha, AttayaSuvannasankha, AttayaJagannath, SundarJagannath, SundarChari, AjaiChari, AjaiClever, DavidClever, DavidKalu, ChidimmaKalu, ChidimmaCollins, ShaunaCollins, ShaunaAlghothani, YousefAlghothani, YousefHofmeister, Craig CHofmeister, Craig CEfebera, YvonneEfebera, YvonneBlanchet, StephaneBlanchet, StephaneCaligiuri, Michael ACaligiuri, Michael AFarag, Sherif and Farag, Sherif
Blood, vol. 116, (no. 21), pp. 1966, 2010-11-19. | Journal Article
 
Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Suvannasankha, AttayaSuvannasankha, AttayaFarag, SherifFarag, SherifObryant, RobinObryant, RobinWood, Lisa lWood, Lisa lPorter, NicolePorter, NicoleAbonour, Rafat and Abonour, Rafat
Blood, vol. 116, (no. 21), pp. 1970, 2010-11-19. | Journal Article
 
Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma
Wang, XiaojingWang, XiaojingWang, XiaojingWang, XiaojingSinn, AnthonySinn, AnthonySinn, AnthonySinn, Anthony LPollok, KarenPollok, KarenPollok, KarenPollok, KarenSandusky, GeorgeSandusky, GeorgeSandusky, GeorgeSandusky, GeorgeZhang, ShuhongZhang, ShuhongZhang, ShuhongZhang, ShuhongChen, LiChen, LiChen, LiChen, LiLiang, JingLiang, JingLiang, JingLiang, JingCrean, Colin DCrean, ColinCrean, ColinCrean, ColinSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaAbonour, RafatAbonour, RafatAbonour, RafatAbonour, RafatSidor, CarolynSidor, CarolynSidor, CarolynSidor, CarolynBray, MarkBray, MarkBray, Mark RBray, MarkFarag, SherifFarag, SherifFarag, Sherif and Farag, Sherif S
British Journal of Haematology, vol. 150, (no. 3), pp. 313-325, 2010. | Journal Article
2009
Multiple Myeloma Derived Factors Generate Tolerogenic Dendritic Cells by Activation of STAT3: A Potential Target for Immunotherapy
Homsi, YaserHomsi, YaserHomsi, YaserChen, LiChen, LiChen, LiZhang, ShuhongZhang, ShuhongZhang, ShuhongLiang, JingLiang, JingLiang, JingSuvannasankha, AttayaSuvannasankha, AttayaSuvannasankha, AttayaAbonour, RafatAbonour, RafatAbonour, RafatFarag, SherifFarag, Sherif and Farag, Sherif
Blood, vol. 114, (no. 22), pp. 3031, 2009-11-20. | Journal Article